Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation
Ying-Nan Tsai, Jia-Ling Wu, Cheng-Hao Tseng, Tzu-Haw Chen, Yi-Ling Wu, Chieh-Chang Chen, Yu-Jen Fang, Tzeng-Huey Yang, Mindie H. Nguyen, Jaw-Town Lin, Yao-Chun Hsu
Clin Mol Hepatol. 2024;30(1):98-108. Published online 2023 Dec 14 DOI: https://doi.org/10.3350/cmh.2023.0194
|
Citations to this article as recorded by
Clinical Significance and Remaining Issues of Anti-HBc Antibody and HBV Core-Related Antigen
Yoshihiko Yano, Itsuko Sato, Takamitsu Imanishi, Ryutaro Yoshida, Takanori Matsuura, Yoshihide Ueda, Yuzo Kodama
Diagnostics.2024; 14(7): 728. CrossRef Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”
Yun-Fan Liaw
Clinical and Molecular Hepatology.2024; 30(2): 269. CrossRef Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
Chen-Te Huang, Tai-Chung Tseng
Clinical and Molecular Hepatology.2024; 30(2): 154. CrossRef Optimizing off-treatment outcome predictions: The potential of time-varying HBcrAg and the need for more research
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
Clinical and Molecular Hepatology.2024; 30(2): 276. CrossRef Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring
Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu
Clinical and Molecular Hepatology.2024; 30(2): 293. CrossRef A critical review of diagnostic and prognostic markers of chronic hepatitis B infection
Shuaibu Abdullahi Hudu, Sa’adatu Haruna Shinkafi, Abdulgafar Olayiwola Jimoh
Medical Review.2024; 4(3): 225. CrossRef Virological markers for clinical trials in chronic viral hepatitis
Jean-Michel Pawlotsky
JHEP Reports.2024; : 101214. CrossRef
|